DASAMIA contains the active substance dasatinib. This medicine is used to treat chronic myeloid leukaemia (CML) in adults. Leukaemia is a cancer of white blood cells. These white cells usually help the body to fight infection. In people with CML, white cells called granulocytes start growing out of control. DASAMIA inhibits the growth of these leukaemic cells.
DASAMIA is also used to treat Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL) and lymphoid blast CML in adults who are not benefiting from prior therapies. In people with ALL, white cells called lymphocytes multiply too quickly and live too long. DASAMIA inhibits the growth of these leukemic cells.